Ole Henrik Eriksen
CEO
Business Development
Genetic Analysis
Sweden
Biography
Over 25 years experience in the pharma-, biotech- and medtech- industries, and has extensive experience in the development and financing of startup companies. He was the first CEO of Clavis Pharma (later Aqualis) and now holds a possition as VP Business Development in Weifa. Eriksen has previously been instrumental in two IPOs.
Research Interest
Biotechnology
